Submitted by Anonymous (not verified) on 12 November 2026 - 15:18
Human medicines European public assessment report (EPAR): Rixathon, rituximab, Date of authorisation: 15/06/2017, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rixathon, rituximab, Date of authorisation: 15/06/2017, Revision: 17, Status: Authorised